GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanosphere Health Sciences Inc (OTCPK:NSHSF) » Definitions » Debt-to-Revenue

NSHSF (Nanosphere Health Sciences) Debt-to-Revenue : N/A (As of Sep. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Nanosphere Health Sciences Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Nanosphere Health Sciences's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $0.03 Mil. Nanosphere Health Sciences's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $0.00 Mil. Nanosphere Health Sciences's annualized Revenue for the quarter that ended in Sep. 2024 was $0.00 Mil.


Nanosphere Health Sciences Debt-to-Revenue Historical Data

The historical data trend for Nanosphere Health Sciences's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanosphere Health Sciences Debt-to-Revenue Chart

Nanosphere Health Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.68 N/A N/A N/A N/A

Nanosphere Health Sciences Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A N/A N/A N/A N/A

Competitive Comparison of Nanosphere Health Sciences's Debt-to-Revenue

For the Biotechnology subindustry, Nanosphere Health Sciences's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanosphere Health Sciences's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanosphere Health Sciences's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Nanosphere Health Sciences's Debt-to-Revenue falls into.



Nanosphere Health Sciences Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Nanosphere Health Sciences's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Nanosphere Health Sciences's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2024) Revenue data.


Nanosphere Health Sciences Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Nanosphere Health Sciences's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanosphere Health Sciences Business Description

Traded in Other Exchanges
Address
1090 West Georgia Street, Suite 488, Vancouver, BC, CAN, V6E 3V7
Nanosphere Health Sciences Inc is a nano-biotechnology company. The company is focused on providing next-generation delivery of nutritive elements and medications. Its NanoSphere Delivery System platform technology addresses the problems of low bioavailability and excessive dosage amounts of a wide range of bioactive compounds. It focuses on developing nanoencapsulation technology for the delivery of nutritive elements and medicants through licensing arrangements.